Guardant Health, Inc. ($GH)
Filing Information
| Accession Number | 0001871615-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
190,815
Total Value
$15,498,618.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 35,412 | $110.49 | $3,912,671.88 | 100,786 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 28,193 | $28.37 | $799,835.41 | 128,979 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Sale | 3,463 | $167.38 | $579,638.67 | 125,516 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Sale | 7,365 | $168.79 | $1,243,144.98 | 118,151 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Sale | 35,364 | $169.63 | $5,998,926.17 | 82,787 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Aug 10, 2026 | Sale | 17,413 | $170.24 | $2,964,401.31 | 65,374 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 35,412 | $0.00 | $0.00 | 3,620 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 28,193 | $0.00 | $0.00 | 1,668 | Direct | โ | View Details |